[go: up one dir, main page]

KR880009961A - 5-클로로-3--2-옥신돌-1-카복스아미드의 무수 결정성 나트륨 염 - Google Patents

5-클로로-3--2-옥신돌-1-카복스아미드의 무수 결정성 나트륨 염

Info

Publication number
KR880009961A
KR880009961A KR1019880000876A KR880000876A KR880009961A KR 880009961 A KR880009961 A KR 880009961A KR 1019880000876 A KR1019880000876 A KR 1019880000876A KR 880000876 A KR880000876 A KR 880000876A KR 880009961 A KR880009961 A KR 880009961A
Authority
KR
South Korea
Prior art keywords
oxinol
carboxamide
chloro
sodium salt
anhydrous crystalline
Prior art date
Application number
KR1019880000876A
Other languages
English (en)
Other versions
KR900001422B1 (ko
Inventor
존 멜드럼 알렌 더글라스
토마스 오'네일 브리안
Original Assignee
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포레이티드 filed Critical 화이자 인코포레이티드
Publication of KR880009961A publication Critical patent/KR880009961A/ko
Application granted granted Critical
Publication of KR900001422B1 publication Critical patent/KR900001422B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019880000876A 1987-02-02 1988-02-01 5-클로로-3-(2-테노일)-2-옥신돌-1-카복스아미드의 무수 결정성 나트륨 염 KR900001422B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
USPCT/US87/00201 1987-02-02

Publications (2)

Publication Number Publication Date
KR880009961A true KR880009961A (ko) 1988-10-06
KR900001422B1 KR900001422B1 (ko) 1990-03-09

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880000876A KR900001422B1 (ko) 1987-02-02 1988-02-01 5-클로로-3-(2-테노일)-2-옥신돌-1-카복스아미드의 무수 결정성 나트륨 염

Country Status (42)

Country Link
US (1) US5036099A (ko)
EP (1) EP0277738B1 (ko)
JP (1) JPS63201184A (ko)
KR (1) KR900001422B1 (ko)
CN (1) CN1022324C (ko)
AP (1) AP52A (ko)
AR (1) AR243182A1 (ko)
AT (1) ATE73800T1 (ko)
AU (1) AU587736B2 (ko)
BG (1) BG51042A3 (ko)
CA (1) CA1335590C (ko)
CS (2) CS265250B2 (ko)
CY (1) CY1775A (ko)
DD (1) DD267490A5 (ko)
DE (1) DE3869149D1 (ko)
DK (1) DK44888A (ko)
EC (1) ECSP941082A (ko)
ES (1) ES2032955T3 (ko)
FI (1) FI89598C (ko)
GR (1) GR3004200T3 (ko)
HK (1) HK132695A (ko)
IE (1) IE60000B1 (ko)
IL (1) IL85277A (ko)
IN (1) IN171799B (ko)
IS (1) IS1533B (ko)
LV (1) LV10252B (ko)
MA (1) MA21171A1 (ko)
MY (1) MY102737A (ko)
NO (1) NO170581C (ko)
NZ (1) NZ223373A (ko)
OA (1) OA08710A (ko)
PH (1) PH26545A (ko)
PL (1) PL149550B1 (ko)
PT (1) PT86675B (ko)
RO (1) RO105052B1 (ko)
RU (1) RU2011381C1 (ko)
SG (1) SG27994G (ko)
SI (1) SI8810183A8 (ko)
UA (1) UA25898A1 (ko)
WO (1) WO1988005656A1 (ko)
YU (1) YU46766B (ko)
ZA (1) ZA88679B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
MX18021A (es) * 1988-10-18 1993-11-01 Pfizer Pro-farmacos de la 3-acil-2-oxindol-1-carboxamidasanti-inflamatorias
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) * 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
WO2019087191A1 (en) 2017-11-02 2019-05-09 Accurate Medical Therapeutics Ltd. Embolization catheter with integral filter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
PT80116B (pt) * 1984-03-19 1987-10-20 Pfizer Processo para a producao de 2-oxindole-1-carboxamidas e de intermediarios para esse efeito
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
DD267490A5 (de) 1989-05-03
CA1335590C (en) 1995-05-16
CN88100555A (zh) 1988-08-17
PL149550B1 (en) 1990-02-28
WO1988005656A1 (en) 1988-08-11
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
US5036099A (en) 1991-07-30
AU1116088A (en) 1988-08-04
CY1775A (en) 1996-04-05
BG51042A3 (en) 1993-01-15
OA08710A (fr) 1989-03-31
PT86675B (pt) 1992-07-31
NO170581C (no) 1992-11-04
NO884329D0 (no) 1988-09-29
MA21171A1 (fr) 1988-10-01
NO884329L (no) 1988-09-29
FI89598B (fi) 1993-07-15
ZA88679B (en) 1989-09-27
DK44888D0 (da) 1988-01-29
ECSP941082A (es) 1994-12-15
SI8810183A8 (sl) 1996-08-31
AP8800081A0 (en) 1987-11-01
IE880269L (en) 1988-08-02
AR243182A1 (es) 1993-07-30
RO105052B1 (en) 1994-12-01
DK44888A (da) 1988-08-03
PH26545A (en) 1992-08-19
YU46766B (sh) 1994-05-10
UA25898A1 (uk) 1999-02-26
PL270415A1 (en) 1988-12-08
AU587736B2 (en) 1989-08-24
IE60000B1 (en) 1994-05-18
IN171799B (ko) 1993-01-09
EP0277738B1 (en) 1992-03-18
CN1022324C (zh) 1993-10-06
DE3869149D1 (de) 1992-04-23
CS354191A3 (en) 1992-04-15
PT86675A (pt) 1988-03-01
GR3004200T3 (ko) 1993-03-31
SG27994G (en) 1994-10-14
YU18388A (en) 1989-10-31
EP0277738A1 (en) 1988-08-10
FI893647A0 (fi) 1989-08-01
MY102737A (en) 1992-09-30
RU2011381C1 (ru) 1994-04-30
ATE73800T1 (de) 1992-04-15
AP52A (en) 1989-09-16
ES2032955T3 (es) 1996-07-16
IL85277A (en) 1994-02-27
CS265250B2 (en) 1989-10-13
IS3309A7 (is) 1988-08-03
IS1533B (is) 1994-01-28
JPH0576945B2 (ko) 1993-10-25
NO170581B (no) 1992-07-27
FI89598C (fi) 1993-10-25
KR900001422B1 (ko) 1990-03-09
CS64888A2 (en) 1988-08-16
LV10252A (lv) 1994-10-20
NZ223373A (en) 1989-06-28
IL85277A0 (en) 1988-07-31
HK132695A (en) 1995-09-01

Similar Documents

Publication Publication Date Title
KR880009961A (ko) 5-클로로-3--2-옥신돌-1-카복스아미드의 무수 결정성 나트륨 염
MX12213A (es) Metodo de preparacion de dihidrato de azitromicina cristalino
ES533183A0 (es) Amoxicilina sodica cristalina
FI942597L (fi) 2-O-alkyyliaskorbiinihapon litiumsuola
FI883803L (fi) Natriumpuriinien valmistusmenetelmä
IT1200125B (it) Composti di cefalosporina e procedimento per produrli
DE3564577D1 (de) 7-d-mandelamido-3-(1-sulfomethyltetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid monosodium salt
FR2540120B1 (fr) Sels de derives organophosphores fongicides
GB8825422D0 (en) Crystallisation of sodium oxalates
ZA862603B (en) Crystalline anhydrous sodium 19-deoxyaglycone dianemycin
CS809187A1 (en) Sodium salt of carboxymethyl-/1-6/-beta-d-gluco-/1-3-beta-d-glucan
JPS6428216A (en) Purification of barium salt
ZA885263B (en) Crystalline monohydrate of sodium n-(1h-tetrazol-5-yl)-1-phenoxy-4h-quinolizin-4-one-3-carboxamide
KR780000599B1 (en) Method for crystallization of sodium salt of 5'-inosinic acid
LV5721B4 (lv) 5-Hlor-3-(2-tenoil-2-oksindola-1-karboksamida bezudens kristaliska natrija sals
SU1139118A1 (ru) Способ получения гликолевой кислоты или ее натриевой соли
GB8304662D0 (en) Sodium salt of hydroxypyrazine
IE882878L (en) Production of anhydrous sodium cyanide crystals
IE870518L (en) Purification of barium salt
FR2553419B1 (fr) Sels de derives organophosphores fongicides
NO874298D0 (no) Fremstilling av stabilt krystallinsk natriumacetylsalisylat.
IE843041L (en) Crystals of sodium cephemcarboxylate
PL256493A1 (en) Method of obtaining sodium salt of 2-metoxyphenoxyacetic acid
GB8721567D0 (en) Salts of cephem compounds
GB8725051D0 (en) Salts of cephem compounds

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19880201

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19880201

Comment text: Request for Examination of Application

PG1501 Laying open of application
G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19900208

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19900518

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19900529

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19900529

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19930126

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19940110

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19950117

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19960212

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19970129

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19980218

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19990113

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20000115

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20010130

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20020124

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20030123

Start annual number: 14

End annual number: 14

FPAY Annual fee payment

Payment date: 20040113

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 20040113

Start annual number: 15

End annual number: 15

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee